Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Biogen Idec
(NQ:
BIIB
)
224.00
-1.58 (-0.70%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jun 21, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Biogen Idec
< Previous
1
2
...
15
16
17
18
19
20
21
22
23
...
38
39
Next >
Why Is Biogen (BIIB) Stock Up 40% Today?
September 28, 2022
Positive results from a clinical trial offer encouragement for the medical community, as well as for downtrodden BIIB stock investors.
Via
InvestorPlace
14 Analysts Have This to Say About Biogen
September 28, 2022
Within the last quarter, Biogen (NASDAQ:BIIB) has observed the following analyst ratings:
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 28, 2022
September 28, 2022
Upgrades
Via
Benzinga
These Analysts Boost Price Targets On Biogen Following Positive Alzheimer's Drug Data, Shares Jump
September 28, 2022
Biogen, Inc. (NASDAQ: BIIB) shares jumped sharply on Wednesday.
Via
Benzinga
Biogen Explodes Higher After Alzheimer's Drug Succeeds In Final-Phase Test
September 28, 2022
The drug not only removed beta amyloid, but led to a cognitive benefit.
Via
Investor's Business Daily
Biogen Settles For $900M In Bribe Case For Prescribing Multiple Sclerosis Drugs
September 27, 2022
Via
Benzinga
Netflix To Rally Around 24%? Here Are 5 Other Price Target Changes For Wednesday
September 28, 2022
Atlantic Equities raised Netflix, Inc. (NASDAQ: NFLX) price target from $211 to $283. Atlantic Equities analyst Hamilton Faber also upgraded the stock from Neutral to Overweight. Netflix shares rose...
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
September 28, 2022
Gainers Acumen Pharmaceuticals (NASDAQ:ABOS) shares increased by 80.8% to $8.5 during Wednesday's pre-market session. The company's market cap stands at $344.2 million.
Via
Benzinga
Is iPhone Demand Really Slowing Down?, Lyft Freezes Hiring, Biogen's New Drug Slows Alzheimer's Progression: Top Financial Media Stories Wednesday, Sept. 28
September 28, 2022
Bloomberg
Via
Benzinga
What In The World Is Going On With Biogen (BIIB) Shares?
September 28, 2022
Biogen Inc (NASDAQ: BIIB) shares are trading higher by 42.62% to $282.08 during Wednesday's pre-market session after the company and Eisai Co.
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
September 28, 2022
It's time for another dive into the biggest pre-market stock movers as we check out what's going on on Wednesday morning.
Via
InvestorPlace
Why Cassava Sciences Shares Are Soaring Higher
September 28, 2022
Cassava Sciences Inc (NASDAQ: SAVA) shares are trading higher by 7.15 to $49.48 during Wednesday's pre-market session after Biogen Inc (NASDAQ: BIIB) and Eisai Co.
Via
Benzinga
What's Going On With Eli Lilly Stock Shooting Higher Today
September 28, 2022
Eli Lilly And Co (NYSE: LLY) shares are trading higher by 7.60% to $334.75 during Wednesday's pre-market session after Biogen Inc (NASDAQ: BIIB) and Eisai Co.
Via
Benzinga
Why MindMed Is Trading Lower By Around 35%; Here Are 31 Stocks Moving Premarket
September 28, 2022
Gainers Atlis Motor Vehicles Inc (NASDAQ: AMV) rose 211.7% to $256.00 in pre-market trading after jumping around 199% on Tuesday.
Via
Benzinga
Nasdaq Futures Slip But S&P 500, Dow Futures Hold Up Ahead Of Market Open — Apple, Biogen Stocks In Focus
September 28, 2022
U.S. stocks could struggle for direction on Wednesday after the market struggled en route to a mixed close in the previous session. Volatility could be the order of the day as another batch of Fed...
Via
Benzinga
Why Biogen Stock Is Up 40% Today
September 28, 2022
Biogen, Inc. (NASDAQ: BIIB) shares are soaring over 43% to their highest level in about a year in premarket trading Wednesday.
Via
Benzinga
Biogen, Eli Lilly And Some Other Big Stocks Moving Higher In Today's Pre-Market Session
September 28, 2022
U.S. stock futures traded lower this morning. Here are some big stocks moving higher in today’s pre-market trading session.
Via
Benzinga
2 Sympathy Plays To Watch For In The Wake Of Biogen's Positive Alzheimer's Drug Data
September 28, 2022
Biogen Inc. (NASDAQ: BIIB) and partner Eisai Co. Ltd.
Via
Benzinga
US Stock Futures Down Ahead Of Fed Speakers, Economic Data
September 28, 2022
Pre-open movers U.S. stock futures traded lower in early pre-market trade on Wednesday after closing mostly lower on Tuesday. The S&P 500 index dropped deeper into a bear market after hitting a fresh...
Via
Benzinga
Alzheimer's Progression Slowed Down By Biogen's New Drug In Late-Stage Study: Analyst Sees 25% Upside For Stock
September 28, 2022
Biogen, Inc. (NASDAQ: BIIB) and Eisai Co. Ltd. (OTC: ESALY) announced late Tuesday positive results from a late-stage study of their Alzheimer’s treatment candidate.
Via
Benzinga
Check Out What Whales Are Doing With BIIB
September 27, 2022
A whale with a lot of money to spend has taken a noticeably bullish stance on Biogen. Looking at options history for Biogen (NASDAQ:BIIB) we detected 19 strange trades.
Via
Benzinga
Elon Musk Twitter Case Deposition Delayed, FTX US Goes Shopping, Spotify's Analyst Sees Audiobooks Immaterial: Top Financial Media Stories Tuesday, Sept. 27
September 27, 2022
Bloomberg
Via
Benzinga
The 'Transformative' Eli Lilly Drug That Could Top $25 Billion In Annual Sales
September 22, 2022
The drug already has one FDA approval as Lilly angles for a second.
Via
Investor's Business Daily
Novavax Price Target Cut By Around 80%, Plus This Analyst Predicts $129 For NIKE
September 22, 2022
Morgan Stanley cut the price target for NIKE, Inc. (NYSE: NKE) from $149 to $129. NIKE shares fell 0.6% to $99.20 on Thursday.
Via
Benzinga
Longer-Term Use, Early Initiation of Biogen's Experimental Drug For Inherited Rare Disease Slows Disease Progression
September 22, 2022
Via
Benzinga
Looking At Biogen's Recent Whale Trades
September 20, 2022
Someone with a lot of money to spend has taken a bearish stance on Biogen (NASDAQ:BIIB). And retail traders should know. We noticed this today when the big position showed up on publicly available...
Via
Benzinga
10 Health Care Stocks Whale Activity In Today's Session
September 15, 2022
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...
Via
Benzinga
Something Unusual Is Happening Right Now With Biotech Stocks Like Catalyst, Vertex, Neurocrine And BioMarin
September 15, 2022
The market is struggling, yet biotech stocks are acting like it's good times again. Here's why.
Via
Investor's Business Daily
Biogen Whale Trades For September 14
September 14, 2022
Someone with a lot of money to spend has taken a bearish stance on Biogen (NASDAQ:BIIB). And retail traders should know. We noticed this today when the big position showed up on publicly available...
Via
Benzinga
Hurry! It’s Time to Take Your Profits From These 7 Stocks
September 13, 2022
Investors are increasingly focused on stocks to sell as they brace for a tough September as the economy's challenges mount.
Via
InvestorPlace
< Previous
1
2
...
15
16
17
18
19
20
21
22
23
...
38
39
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.